section name header

Pronunciation

oh-FLOX-a-sin audio

Indications

REMS

Action

Therapeutic Effects:

Spectrum:

Pharmacokinetics

Absorption: Well absorbed (98%) following oral administration.

Distribution: Widely distributed. High tissue and urinary levels are achieved. Appears to cross the placenta; enters breast milk.

Metabolism/Excretion: 70–80% excreted unchanged by the kidneys.

Half-life: 5–7 hr.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: AORTIC ANEURYSM/DISSECTION, TORSADE DE POINTES, QT interval prolongation.

Derm: STEVENS-JOHNSON SYNDROME, photosensitivity, rash.

Endo: hyperglycemia, hypoglycemia.

GI: CLOSTRIDIOIDES DIFFICILE-ASSOCIATED DIARRHEA (CDAD), abdominal pain, diarrhea, nausea, vomiting.

GU: vaginitis.

MS: arthralgia, myalgia, tendinitis, tendon rupture.

Neuro: peripheral neuropathy , ELEVATED INTRACRANIAL PRESSURE (INCLUDING PSEUDOTUMOR CEREBRI), SEIZURES, SUICIDAL THOUGHTS, agitation, anxiety, confusion, depression, dizziness, hallucinations, headache, insomnia, nightmares, paranoia, toxic psychosis, tremor.

Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS).

Interactions

Drug-Drug:

Drug-Food:

Route/Dosage

Acute Bacterial Exacerbations of Chronic Bronchitis

Community-Acquired Pneumonia

Uncomplicated Skin/Skin Structure Infections

Uncomplicated Urethral and Cervical Gonorrhea

Nongonococcal Urethritis/Cervicitis

Mixed Infection of the Urethra and Cervix

Acute Pelvic Inflammatory Disease

Urinary Tract Infections

Prostatitis

Renal Impairment

Implementation

US Brand Names

Floxin, Floxin Otic

Classifications

Therapeutic Classification: anti-infectives

Pharmacologic Classification: Fluoroquinolones

Availability

(Generic available)

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
POrapid1–2 hr12 hr

Assessment

Lab Test Considerations:

Pot. Nursing Diagnoses

Patient/Family Teaching

Evaluation/Desired Outcomes

Code

NDC Code*